These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30871174)

  • 1. Potential of the Other Genetic Information Coded by the Viral RNA Genomes as Antiviral Target.
    Berzal-Herranz A; Romero-López C; Berzal-Herranz B; Ramos-Lorente S
    Pharmaceuticals (Basel); 2019 Mar; 12(1):. PubMed ID: 30871174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA Aptamers as Molecular Tools to Study the Functionality of the Hepatitis C Virus CRE Region.
    Fernández-Sanlés A; Berzal-Herranz B; González-Matamala R; Ríos-Marco P; Romero-López C; Berzal-Herranz A
    Molecules; 2015 Sep; 20(9):16030-47. PubMed ID: 26364632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Examples of RNA Aptamers with Antiviral Activity. Are Aptamers the Wished Antiviral Drugs?
    Berzal-Herranz A; Romero-López C
    Pharmaceuticals (Basel); 2020 Jul; 13(8):. PubMed ID: 32707768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HCV RNA Aptamers Targeting the Genomic cis-Acting Replication Element.
    Marton S; Berzal-Herranz B; Garmendia E; Cueto FJ; Berzal-Herranz A
    Pharmaceuticals (Basel); 2011 Dec; 5(1):49-60. PubMed ID: 24288042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An engineered inhibitor RNA that efficiently interferes with hepatitis C virus translation and replication.
    Romero-López C; Berzal-Herranz B; Gómez J; Berzal-Herranz A
    Antiviral Res; 2012 May; 94(2):131-8. PubMed ID: 22426470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.
    González VM; Martín ME; Fernández G; García-Sacristán A
    Pharmaceuticals (Basel); 2016 Dec; 9(4):. PubMed ID: 27999271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Information Stored in the Conserved Structural RNA Domains of Flavivirus Genomes.
    Fernández-Sanlés A; Ríos-Marco P; Romero-López C; Berzal-Herranz A
    Front Microbiol; 2017; 8():546. PubMed ID: 28421048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C viral protein translation: mechanisms and implications in developing antivirals.
    Hoffman B; Liu Q
    Liver Int; 2011 Nov; 31(10):1449-67. PubMed ID: 21745290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Analysis of Serum-Derived Defective Hepatitis C Virus Genomes Revealed Novel Viral
    Li Q; Tong Y; Xu Y; Niu J; Zhong J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecules targeting viral RNA.
    Hermann T
    Wiley Interdiscip Rev RNA; 2016 Nov; 7(6):726-743. PubMed ID: 27307213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
    Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
    J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cis-acting replication element of the Hepatitis C virus genome recruits host factors that influence viral replication and translation.
    Ríos-Marco P; Romero-López C; Berzal-Herranz A
    Sci Rep; 2016 May; 6():25729. PubMed ID: 27165399
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Coffman SR; Lu J; Guo X; Zhong J; Jiang H; Broitman-Maduro G; Li WX; Lu R; Maduro M; Ding SW
    mBio; 2017 Mar; 8(2):. PubMed ID: 28325765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.
    Blight KJ; Kolykhalov AA; Reed KE; Agapov EV; Rice CM
    Antivir Ther; 1998; 3(Suppl 3):71-81. PubMed ID: 10726057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.
    Bukh J
    J Hepatol; 2016 Oct; 65(1 Suppl):S2-S21. PubMed ID: 27641985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Form confers function: Case of the 3'X region of the hepatitis C virus genome.
    Dutkiewicz M; Ciesiołka J
    World J Gastroenterol; 2018 Aug; 24(30):3374-3383. PubMed ID: 30122877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4.
    Stoddard MB; Li H; Wang S; Saeed M; Andrus L; Ding W; Jiang X; Learn GH; von Schaewen M; Wen J; Goepfert PA; Hahn BH; Ploss A; Rice CM; Shaw GM
    mBio; 2015 Feb; 6(2):e02518. PubMed ID: 25714714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome.
    Romero-López C; Lahlali T; Berzal-Herranz B; Berzal-Herranz A
    Molecules; 2017 May; 22(5):. PubMed ID: 28531161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Hepatitis E Viruses Harboring Tags in the ORF1 Protein.
    Szkolnicka D; Pollán A; Da Silva N; Oechslin N; Gouttenoire J; Moradpour D
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Methods to Decipher the Structure of Viral RNA Genomes.
    Romero-López C; Ramos-Lorente SE; Berzal-Herranz A
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.